HOXA13 and neoplasm: N6-methyladenosine (m6A) RNA binding protein YTHDC2 can directly inhibit SLC7A11 on the one hand, and destabilize the mRNA of transcription factor HOXA13 in an m6A dependent manner, thereby inhibiting HOXA13-mediated transcription of SLC3A2, thereby damaging tumor growth.